An additional supply of COVID-19 investigational drug tocilizumab may arrive by the second week of November, DOH said. | cgonzalesINQ
“Itong tocilizumab ang medyo nagkaroon tayo ng problema and according sa manufacturer nila, sa supplier nila na kausap natin dito, baka by second week of
November, magkaroon tayo ng stocks. So hihintayin natin ulit,” Health Undersecretary Maria Rosario Vergeire told an online media briefing.FEATURED STORIES
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DOH logs 3,218 new COVID-19 cases, lowest in over 5 monthsThe country recorded 3,218 new COVID-19 infections on Wednesday, the lowest in over five months, pushing the nationwide total to 2,768,849, the Department of Health reported.
Read more »
DOH: 25 children experience adverse reactions after getting COVID-19 jabTwenty-five children with comorbidities aged 12 to 17 experienced adverse reactions after receiving a COVID-19 vaccine, the Department of Health (DOH) said.
Read more »
DOH reports over 3,000 new Covid-19 cases, recoveriesTHE Department of Health (DOH) announced Thursday, October 28, 3,694 new cases of coronavirus disease (Covid-19) that brought the country’s total...
Read more »
DOH: New stock of tocilizumab may be available in NovemberThe country may soon receive a fresh supply of tocilizumab, a repurposed drug for COVID-19, Health Undersecretary Maria Rosario Vergeire said Friday
Read more »
DOH emphasizes importance of health screening on local travelersThe Department of Health (DOH) said it is still recommending that provincial local government units still strictly conduct a health screening for travelers going to their areas to prevent transmission of COVID-19.
Read more »
DOH: New stock of tocilizumab may be available in NovemberThe country may soon receive a fresh supply of tocilizumab, a repurposed drug for COVID-19, Health Undersecretary Maria Rosario Vergeire said Friday
Read more »